Back

GLP-1 receptor agonists are associated with higher mitochondrial coupling efficiency in the human heart

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Advances in heart transplantation Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Philipp Gabert

Duesseldorf (Germany)

5 More presentations in this session

Presentation thumbnail
Sensitization in adults with congenital heart disease evaluated for heart transplantation: prevalence and impact on 1-year post-transplant outcomes
Doctor I. Marco Clement (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
snoRNAs signature for detection of cardiac rejection after heart transplantation
Miss C. Benedicto Marrero (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Diagnostic accuracy of non-invasive imaging to evaluate heart transplant recipients: a systematic review and meta-analysis
Doctor G. La Vecchia (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Comprehensive non-invasive versus invasive approach to evaluate cardiac allograft vasculopathy in heart transplantation
Doctor M. Belmonte (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Five-year outcomes of heart transplantation from HCV-viremic donors: insights from the national registry
Doctor M. Mazur (Cleveland, US)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in heart transplantation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on mitochondrial-derived peptide-c and on markers of neurohumoral activation
thumbnail
Congress Presentation
Validation of mitochondrial function measurements in permeabilized myocardial tissue from porcine left ventricular specimens with ischemia/reperfusion
thumbnail
Congress Presentation
Lower mitochondrial ketone body oxidation capacity in the human diabetic heart

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources